Genetics in Neural Toxicities of Drugs

Author(s): Da-Yong Lu, Ting-Ren Lu, Peng-Peng Zhu.

Journal Name: Central Nervous System Agents in Medicinal Chemistry

Volume 12 , Issue 4 , 2012

Become EABM
Become Reviewer


Adverse side effects or toxicities of a drug were previously regarded as a manifestation of drug’s own characterizations, such as the chemical structure and property of a drug. More recently, increasing experimental or clinical data and modern ideas suggest that human’s genetic factors also play indispensable roles in resulting neural side effects of a drug, especially in antidepressant-induced suicide and antibiotics-induced hearing loss. However, there are many questions and technological obstacles (including high costs and limited samples) in these kinds of researches and this makes genetic study of drug toxicities in its initial stage. In this review, we in depth address and analysis of this matter from some new perspectives and propose some new initiatives to improve this type of researches in future. It is also highly needed to expedite the translation of these pharmacogenetic concepts from bench to bedside.

Keywords: Side effects of drug, human genome, neural toxicity, antidepressant, antibiotics, genetics, drug develop, drug safety, medicinal chemistry, genomic study, pharmacogenomics, mental toxicity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [250 - 253]
Pages: 4
DOI: 10.2174/187152412803760591
Price: $58

Article Metrics

PDF: 12